Connect with us

Technology

InMode to Report First Quarter 2025 Financial Results and Hold Conference Call on April 28, 2025, Expects Q1 Revenue Between $77.2M-$77.5M, Reiterates FY 2025 Revenue Guidance Between $395M-$405M

Published

on

Conference call to be held on Monday, April 28, 2025, at 8:30 a.m. Eastern Time

YOKNEAM, Israel, April 14, 2025 /PRNewswire/ — InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the first quarter 2025 before the Nasdaq market opens on Monday, April 28, 2025.

InMode is currently finalizing its financial results for the first quarter of 2025. While complete financial information and operating data are not yet available, set forth below are certain preliminary results of InMode’s financial results for such period, subject to final adjustments and other developments that may arise between now and the time such financial results are finalized. Based on preliminary results, management expects:

Revenue for the first quarter of 2025 to be in the range of $77.2 million to $77.5 millionNon-GAAP1 gross margin to be in the range of 78% to 79%Full year 2025 revenue to be in the range of $395 million to $405 million

1Please refer to “Use of Non-GAAP Financial Measure” below for important information about non-GAAP financial measures. Non-GAAP results exclude share-based compensation.

InMode will host a conference call to discuss the first quarter 2025 financial results on Monday, April 28, 2025, at 8:30 a.m. Eastern Daylight Time with presentations from management including Moshe Mizrahy, Chief Executive Officer, Yair Malca, Chief Financial Officer and Dr. Michael Kreindel, Chief Technology Officer.

The Company encourages participants to pre-register for the conference call using the following link: https://dpregister.com/sreg/10198516/fede138cb8. Callers will receive a unique dial-in upon registration, which enables immediate access on the day of the call. Participants may pre-register at any time, including up to and after the call start time.

For callers that opt out of pre-registration, please dial one of the following teleconferencing numbers. Please begin by placing your call 10 minutes before the conference call commences. If you are unable to connect using the toll-free number, please try the international dial-in number.

U.S. Toll-Free: 1-833-316-0562
Israel Toll-Free: 1-80-921-2373
International: 1-412-317-5736                                                                                      

Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=jNwaTGkH

At:

8:30 a.m. Eastern Time
5:30 a.m. Pacific Time

The conference call will also be webcast live from a link on InMode’s website at https://inmodemd.com/investors/events-presentations/. A replay of the conference call will be available from April 28, 2025, at 12:00 p.m. Eastern Time to May 12, 2025, at 11:59 p.m. Eastern Time. To access the replay, please dial one of the following numbers:

Replay U.S. TOLL-FREE: 1-877-344-7529
Replay TOLL/INTERNATIONAL: 1-412-317-0088
Replay Pin Number: 3039661

A replay will also be available for 90 days on InMode’s website at: https://inmodemd.com/investors/events-presentations/

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency (“RF”) technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.

Forward-Looking Statements

The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode’s future financial or operating performance, including the 2025 revenue projection described above. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” “would” and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management’s current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode’s Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 04, 2025, and our future public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.

Use of Non-GAAP Financial Measures

In addition to InMode’s operating results presented in accordance with GAAP, this release includes non-GAAP gross margin. Because this measure is used in InMode’s internal analysis of financial and operating performance, management believes that it provides greater transparency to investors of management’s view of InMode’s economic performance. Management also believes the presentation of this measure, when analyzed in conjunction with InMode’s GAAP operating results, allows investors to evaluate and compare the performance of InMode to that of its peers, although InMode’s presentation of its non-GAAP measure may not be comparable to other similarly titled measures of other companies more effectively.

Logo – https://mma.prnewswire.com/media/1064477/5263935/InMode_Logo.jpg

Company Contact:

Yair Malca

Chief Financial Officer

Email: Yair.Malca@inmodemd.com

Investor Relations Contact:

Miri Segal

MS-IR LLC

Email: ir@inmodemd.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/inmode-to-report-first-quarter-2025-financial-results-and-hold-conference-call-on-april-28–2025–expects-q1-revenue-between-77-2m-77-5m-reiterates-fy-2025-revenue-guidance-between-395m-405m-302426673.html

SOURCE InMode Ltd.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

GEEKOM Targets Korea with High-Performance Mini PCs

Published

on

By

TAIPEI, April 29, 2025 /PRNewswire/ — GEEKOM, a Taiwanese tech company known as the Green Mini PC Global Leader, has announced its strategic focus on South Korea as a major target market in 2025, unveiling multiple cutting-edge models designed to cater to diverse computing needs. This move underscores GEEKOM‘s commitment to expanding its presence in Asia and delivering innovative solutions to tech-savvy consumers.

Mini PCs offer a compact, space-saving alternative to traditional desktop towers, making them ideal for modern workspaces or smaller living environments. Despite their size, mini PCs often deliver impressive performance, integrating advanced processors and storage solutions. They consume less power, reducing electricity bills and environmental impact. Known for their outstanding quality, GEEKOM Mini PCs are popular in markets including USA, Western Europe and Australia.

Most of GEEKOM‘s popular models are now available for purchase on Coupang and Naver, including those recently showcased at CES 2025. Leading the lineup is the fan-favorite GEEOM IT13 2025 Edition, equipped with an Intel Core i9-13900HK processor, dual-channel DDR4-3200MHz RAM and a fast PCIe Gen4 SSD. Thanks to its powerful performance and unmatched versatility, the IT13 2025 Edition is well-suited for all sorts of computing scenarios.

Another high-performance solution is the A8 MAX. Equipped with the AMD Ryzen 9 8945HS processor and Radeon 780M iGPU, it delivers exceptional performance for demanding chores like 4K video editing, graphic design, and multitasking. Its built-in NPU enhances AI-driven applications, offering up to 60% faster performance for compatible software. With dual USB4 ports, the mini PC even supports external GPUs for even greater versatility, perfect for creative professionals and tech enthusiasts seeking top-tier performance in a sleek design.

For budget-conscious users, the GEEKOM A6 provides an affordable yet powerful alternative. Priced below $500, it features AMD’s Ryzen R7-6800H processor and shares many of the A8 Max’s core functionalities, including extensive connectivity and storage options. This model is extremely appealing to users seeking value without compromising on performance.

GEEKOM‘s decision to target South Korea aligns with the country’s reputation as a hub for technological innovation and consumer demand for high-quality electronics. By introducing these models, GEEKOM aims to capture the attention of Korean consumers who prioritize performance, reliability, and cutting-edge design.

As GEEKOM continues to innovate, its focus on Korea signals a promising future for the brand in one of the world’s most dynamic tech markets.

 

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/geekom-targets-korea-with-high-performance-mini-pcs-302439060.html

SOURCE GEEKOM

Continue Reading

Technology

Emeren Group Ltd Announces Appointment of Financial Advisor and Legal Counsel to the Special Committee

Published

on

By

NORWALK, Conn., April 28, 2025 /PRNewswire/ — Emeren Group Ltd (“Emeren” or the “Company”) (www.emeren.com) (NYSE: SOL), a leading global solar project developer, owner, and operator, today announced that the special committee (the “Special Committee”) of the Company’s Board of Directors (the “Board”) has retained Kroll, LLC as its independent financial advisor and Morrison & Foerster as its U.S. legal counsel. The Special Committee was formed to evaluate and consider the preliminary non-binding proposal received by the Board on March 17, 2025 (the “Proposal”) as well as other potential strategic alternatives that the Company may pursue.

The Board cautions the Company’s shareholders and others considering trading the Company’s securities that no decisions have been made with respect to the Proposal or any alternative strategic option that the Company may pursue. There can be no assurance that any definitive offer will be received, that any definitive agreement will be executed relating to the transaction contemplated by the Proposal or that any other transaction will be approved or consummated. The Company does not undertake any obligation to provide any updates with respect to any transaction, except as required under applicable law.

About Emeren Group Ltd

Emeren Group Ltd (NYSE: SOL), a renewable energy leader, showcases a comprehensive portfolio of solar projects and Independent Power Producer (IPP) assets, complemented by a significant global Battery Energy Storage System (BESS) capacity. Specializing in the entire solar project lifecycle — from development through construction to financing — we excel by leveraging local talent in each market, ensuring our sustainable energy solutions are at the forefront of efficiency and impact. Our commitment to enhancing solar power and energy storage underlines our dedication to innovation, excellence, and environmental responsibility. For more information, go to www.emeren.com

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “targets, “confident” and similar statements. Among other things, statements that are not historical facts, including statements about Emeren’s beliefs and expectations, the business outlook and quotations from management in this announcement, as well as Emeren’s strategic and operational plans, are or contain forward-looking statements. Emeren may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its periodic reports to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. All forward-looking statements are based upon management’s expectations at the time of the statements and involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: execution of Emeren’s strategies and business plans; growth and trends of the industries in which Emeren operates; market acceptance of Emeren’s products and services; competition in the industries in which Emeren operates; Emeren’s ability to control costs and expenses; Emeren’s ability to retain key personnel and attract new talent; relevant government policies and regulations relating to Emeren’s industry, corporate structure and business operations; seasonality in the business; fluctuations in currencies exchange rates; risks related to acquisitions or investments Emeren has made or will make in the future; accounting adjustments that may occur during the quarterly or annual close or auditing process; and fluctuations in general economic, political, geopolitical and business conditions. Further information regarding these and other risks are included in Emeren’s filings with the U.S. Securities and Exchange Commission. All information provided in this announcement and in the attachments is as of the date of the announcement and based on assumptions that Emeren believes to be reasonable as of this date, and Emeren undertakes no obligation to update any forward-looking statement, except as required under applicable law.

For investor and media inquiries, please contact: 

Emeren Group Ltd – Investor Relations
+1 (925) 425-7335
ir@emeren.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/emeren-group-ltd-announces-appointment-of-financial-advisor-and-legal-counsel-to-the-special-committee-302440285.html

SOURCE Emeren Group Ltd

Continue Reading

Technology

AI Evolution and Life Sciences: Embracing New Frontiers at Dalton Venture CEO Summit 2025

Published

on

By

 HONG KONG, April 29, 2025 /PRNewswire/ — Dalton Venture CEO Summit 2025 , jointly hosted by Dalton Venture and Hong Kong Science and Technology Parks Corporation (HKSTP), successfully concluded at Hong Kong Science Park. The summit brought together over 100 distinguished guests, including government officials, leading scholars, entrepreneurs, and investors from Mainland China, Hong Kong, and beyond, to explore new global opportunities in life sciences innovation.

The event gathered more than 60 entrepreneurs from Dalton Venture’s portfolio companies across cutting-edge sectors such as cell and gene therapy, ophthalmology, AI in healthcare, embodied AI, bio-3D-printing, and cardiovascular technologies.

Uniting Industry, Research, and Capital to Accelerate Globalization

Founding Managing Partner Sun Qi highlighted Hong Kong’s unique advantages as an East-West bridge, with world-class research infrastructure and capital markets. “Dalton Venture sees Hong Kong not only as a gateway to the world but as a convergence point for technology, capital, industry, and vision,” as he said.

Ms. Cheong Man Lei, Lillian, JP, Deputy Secretary for Innovation, Technology and Industry of the Hong Kong SAR Government, delivered a video keynote address. She emphasized Hong Kong’s commitment to becoming an international innovation and technology hub, citing initiatives like the HK$10 billion Research, Academic and Industry Sectors One-plus Scheme. She warmly welcomed more Mainland Chinese enterprises to leverage Hong Kong’s platform for international expansion.

Hong Kong Science Park as a Launchpad for Life Sciences Innovation

Ms. Gracie Ng, Chief of Staff and Acting Chief Corporate Development Officer of HKSTP, also extended a warm welcome. She highlighted HKSTP’s role in cultivating a vibrant life sciences ecosystem through research support, incubation services, and funding channels, including its HK$1 billion corporate venture fund. “We are delighted to host Dalton Venture’s CEO Summit and look forward to deepening collaboration with visionary enterprises.”

Capital Empowering Innovation: Insights from HKEX

Sam S.K. Luk, Vice President (Global Issuer Services) at Hong Kong Exchanges and Clearing Limited (HKEX), outlined Hong Kong’s latest initiatives to support biotech and hard-tech enterprises through listing mechanisms like Chapter 18A and 18C. He emphasized that Hong Kong remains a preferred destination for innovative companies seeking global investors, citing recent resilience in the local stock market and continued inflows from Southbound trading under the Stock Connect program.

Thought Leadership on Frontier Technologies

The summit also featured keynote speeches from leading scientists and entrepreneurs.

Professor Lam Hon Ming, Distinguished Professor of Life Sciences at The Chinese University of Hong Kong, and Director of the State Key Laboratory of Agrobiotechnology shared insights on agricultural biotechnology and sustainability.

Professor Sirui Han, representing Professor Guo Yike, Chief Vice President of the Hong Kong University of Science and Technology and Director of the Hong Kong Center for Generative Artificial Intelligence Research and Development, discussed the evolution of large AI models and their transformative impact on life sciences.

Strengthening Cross-Border Innovation Bridges

Prior to the summit, Dalton Venture organized a closed-door dialogue with InvestHK and the Office for Attracting Strategic Enterprises (OASES), connecting over 30 Mainland biotech companies with Hong Kong’s innovation and policy resources. Discussions focused on leveraging Hong Kong as a springboard for global clinical development, regulatory pathways, and international fundraising.

Looking Ahead: Building a Global Innovation Network

Mr. Huang Ning, Founding Partner of Dalton Venture, concluded the summit by reaffirming Dalton’s commitment to empowering entrepreneurs and accelerating the globalization of life sciences innovation.

As innovation continues to reshape the life sciences sector, Dalton Venture remains dedicated to fostering a robust, interconnected ecosystem that links research, capital, and industry across borders — advancing healthcare for a better future.

CONTACT
Name: Lynn Ning
Email: ningx@daltonventure.cn

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/ai-evolution-and-life-sciences-embracing-new-frontiers-at-dalton-venture-ceo-summit-2025-302439483.html

SOURCE Dalton Venture

Continue Reading

Trending